References
Original article
Moore, K. N. et al. Mirvetuximab soravtansine in FRα-positive, platinum-resistant ovarian cancer. N. Engl. J. Med. 389, 2162–2174 (2023)
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Sidaway, P. Mirvetuximab soravtansine superior to chemotherapy in platinum-resistant epithelial ovarian cancer. Nat Rev Clin Oncol 21, 83 (2024). https://doi.org/10.1038/s41571-023-00851-1
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41571-023-00851-1
- Springer Nature Limited